Providence Medical Technology enrolled its first patients for a randomized controlled trial for its Corus-LX system for degenerative lumbosacral disease, according to a March 19 news release.
The multicenter trial will focus on patients who qualify for two-level interbody fusion with supplemental percutaneous pedicle screw fixation and posterior fusion. Subjects will either have surgery with the Corus-Lx system or with a standard posterior fusion technique.
Kade Huntsman, MD, of the Huntsman Spinal Clinic in Salt Lake City, was the first clinical investigator to treat an enrolled patient with the Corus-Lx device. He used a circumferential fusion approach and integrated lumbar interbody fusion with percutaneous pedicle screws and the CORUS-LX System.
The study aims to evaluate subjects through 2027.
